The vital capacity is vital epidemiology and clinical significance of the restrictive spirometry pattern

Chest

Volumn 149, Issue 1, 2016, Pages 238-251

  Godfrey, Mark S ^a   Jankowich, Matthew D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Lung function; Pulmonary; Spirometry

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPOSURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL DISEASE; GENETIC RISK; HUMAN; INFLAMMATION; LUNG VOLUME; METABOLIC SYNDROME X; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; RESTRICTIVE SPIROMETRY PATTERN; RISK FACTOR; SPIROMETRY; THORAX RADIOGRAPHY; ADULT; FEMALE; LUNG DISEASES, OBSTRUCTIVE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; VITAL CAPACITY;

ADULT; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; SPIROMETRY; VITAL CAPACITY;

EID: 84954112181     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1045     Document Type: Review

References (89)

1. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364(10):897-906.
2. Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15(1):89.
3. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest. 2009;135(2):419-424.
4. van den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: A metaanalysis. Chest. 2010;138(2):393-406.
5. Kim HK, Kim CH, Jung YJ, et al. Association of restrictive ventilatory dysfunction with insulin resistance and type 2 diabetes in Koreans. Exp Clin Endocrinol Diabetes. 2011;119(1):47-52.
6. Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: The critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179(6):509-516.
7. Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008;134(4):712-718.
8. Lin W, Yao C, Wang H, Huang K. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring). 2006;14(9):1654-1661.
9. Fimognari FL, Pasqualetti P, Moro L, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci. 2007;62(7):760-765.
10. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: A longitudinal study. Thorax. 2010;65(6): 499-504.
11. Soriano JB, Miravitlles M, García-Río F, et al. Spirometricallydefined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187-193.
12. Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57-63.
13. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003;254(6): 540-547.
14. Burney P, Jithoo A, Kato B, et al. Chronic obstructive pulmonary disease mortality and prevalence: The associations with smoking and poverty-A BOLD analysis. Thorax. 2014;69(5):465-473.
15. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388-393.
16. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100(1):115-122.
17. Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49-54.
18. Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis. 2005;9(6):613-621.
19. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
20. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143(5):1395-1406.
21. Choudhary G, Jankowich M, Wu WC. Prevalence and clinical characteristics associated with pulmonary hypertension in African-Americans. PLoS One. 2013;8(12):e84264.
22. Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung study. Am J Respir Crit Care Med. 2009;180(5):407-414.
23. Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-Aged cohort. Thorax. 2008;63(7):599-605.
24. Georgiopoulou VV, Kalogeropoulos AP, Psaty BM, et al. Lung function and risk for heart failure among older adults: The Health ABC Study. Am J Med. 2011;124(4):334-341.
25. Eriksson B, Lindberg A, Möllerova H, Rönmark E, Lundbäck B. Association of heart diseases with COPD and restrictive lung function-results from a population survey. Respir Med. 2013; 107(1):98-106.
26. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179-187.
27. Berglund E, Birath G, Bjure J, et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand. 1963;173:185-192.
28. Ng TP, Tan WC, Hui KP. Ventilatory function measured with the micro spirometer: performance evaluation and reference values. Ann Acad Med Singapore. 1995;24(3):403-410.
29. Standardization of Spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
30. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis (Seoul). 2005;58(3): 230-242.
31. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
32. Ferdinands JM, Mannino DM, Gwinn ML, Bray MS. ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study. PLoS One. 2007;2(3):e289.
33. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis. 1976;113(5):587-600.
34. Feng L, Lim ML, Collinson S, Ng TP. Pulmonary function and cognitive decline in an older Chinese population in Singapore. COPD. 2012;9(5):555-562.
35. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med. 2008;102(9):1349-1354.
36. Mannino DM, McBurnie MA, Tan W, et al. Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis. 2012; 16(10):1405-1411.
37. Demedts M, Wells AU, Antó JM, et al. Interstitial lung diseases: An epidemiological overview. Eur Respir J Suppl. 2001;32:2s-16s.
38. Scarlata S, Pedone C, Conte ME, Incalzi RA. Accuracy of spirometry in diagnosing pulmonary restriction in elderly people. J Am Geriatr Soc. 2009;57(11):2107-2111.
39. Braun L. Breathing Race Into the Machine: The Surprising Career of the Spirometer from Plantation to Genetics. Minneapolis, MN: University of Minnesota Press; 2014.
40. Loth DW, Artigas MS, Gharib SA, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669-677.
41. Abbasi IN, Ahsan A, Nafees AA. Correlation of respiratory symptoms and spirometric lung patterns in a rural community setting, Sindh, Pakistan: A cross sectional survey. BMC Pulm Med. 2012;12(1):81.
42. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007;370(9589):741-750.
43. Berger KI, Reibman J, Oppenheimer BW, Vlahos I, Harrison D, Goldring RM. Lessons from the World Trade Center disaster: Airway disease presenting as restrictive dysfunction. Chest. 2013;144(1): 249-257.
44. Skloot GS, Schechter CB, Herbert R, et al. Longitudinal assessment of spirometry in the World Trade Center medical monitoring program. Chest. 2009;135(2):492-498.
45. Kleinman EJ, Cucco RA, Martinez C, et al. Pulmonary function in a cohort of New York City Police Department emergency responders since the 2001 World Trade Center disaster. J Occup Environ Med. 2011;53(6):618-626.
46. Friedman SM, Maslow CB, Reibman J, et al. Case-control study of lung function in World Trade Center Health Registry area residents and workers. Am J Respir Crit Care Med. 2011;184(5):582-589.
47. Caplan-Shaw CE, Yee H, Rogers L, et al. Lung pathologic findings in a local residential and working community exposed to World Trade Center dust, gas, and fumes. J Occup Environ Med. 2011;53(9): 981-991.
48. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain and adult lung function. Thorax. 2009;64(3):228-232.
49. Pei L, Chen G, Mi J, et al. Low birth weight and lung function in adulthood: retrospective cohort study in China, 1948-1996. Pediatrics. 2010;125(4):e899-e905.
50. United Nations Children's Fund and World Health Organization. Low Birthweight: Country, regional and global estimates. New York, NY: UNICEF; 2004:8-20.
51. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med. 1998;338(9):581-587.
52. Gauderman WJ, Urman R, Avol E, et al. Association of improved air quality with lung development in children. N Engl J Med. 2015; 372(10):905-913.
53. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation. 2009;120(16): 1640-1645.
54. Lee HM, Chung SJ, Lopez VA, Wong ND. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171-176.
55. Lim SY, Rhee EJ, Sung KC. Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010; 25(10):1480-1486.
56. Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and extreme obesity among adults: United States, 1960-1962 Through 2011-2012. CDC, Division of Health and Nutrition Examination Surveys. http://www.cdc.gov/nchs/data/hestat/obesity-adult-11-12/obesity-Adult-11-12.pdf. Accessed April 28, 2015.
57. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006;61(6):472-477.
58. Steier J, Lunt A, Hart N, Polkey MI, Moxham J. Observational study of the effect of obesity on lung volumes. Thorax. 2014;69(8): 752-759.
59. Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13(4):203-210.
60. Clavellina-Gaytán D, Velázquez-Fernández D, Del-Villar E, et al. Evaluation of spirometric testing as a routine preoperative assessment in patients undergoing bariatric surgery. Obes Surg. 2015;25(3):530-536.
61. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: A longitudinal cohort study. J Intern Med. 2003;253(5):574-581.
62. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function: A population-based cohort study. Diabet Med. 2002;19(2):167-170.
63. Lazarus R, Sparrow D, Weiss ST. Impaired ventilatory function and elevated insulin levels in nondiabetic males: The Normative Aging Study. Eur Respir J. 1998;12(3):635-640.
64. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: The Normative Aging Study. Eur Respir J. 1998;12(3):641-645.
65. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes: The Normative Aging Study. Respir Med. 2005;99(12):1583-1590.
66. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(6):1472-1479.
67. Wannamethee SG, Shaper AG, Rumley A, et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care. 2010;33(9):1990-1996.
68. Heianza Y, Arase Y, Tsuji H, et al. Low lung function and risk of type 2 diabetes in Japanese men: The Toranomon Hospital Health Management Center Study 9 (TOPICS 9). Mayo Clin Proc. 2012; 87(9):853-861.
69. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004;27(12):2966-2970.
70. Aronson D, Roterman I, Yigla M, et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med. 2006;174(6):626-632.
71. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003;114(9):758-762.
72. Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: The CARDIA Study. Int J Epidemiol. 2006;35(4):1001-1008.
73. Kalhan R, Tran BT, Colangelo LA, et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010;5(7):e11431.
74. Engström G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106(20):2555-2560.
75. Vaz Fragoso CA, Gill TM, McAvay G, Yaggi HK, Van Ness PH, Concato J. Respiratory impairment and mortality in older persons: A novel spirometric approach. J Investig Med. 2011;59(7):1089-1095.
76. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962-969.
77. Mannino DM, Davis KJ, Disantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology. 2013;18(7):1083-1088.
78. Choudhary G, Jankowich M, Wu WC. Elevated pulmonary artery systolic pressure predicts heart failure admissions in African Americans: Jackson Heart Study. Circ Heart Fail. 2014;7(4):558-564.
79. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003;163(12):1475-1480.
80. Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax. 2007;62(1):51-56.
81. Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: The Atherosclerosis Risk in Communities (ARIC) Study. Eur J Neurol. 2011;18(6):888-898.
82. Hickson DA, Liu J, Bidulescu A, Burchfiel CM, Taylor HA, Petrini MF. Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: The Jackson Heart Study. Chest. 2011;140(6):1567-1573.
83. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511-522.
84. Venkateshiah SB, Ioachimescu OC, McCarthy K, Stoller JK. The utility of spirometry in diagnosing pulmonary restriction. Lung. 2008;186(1):19-25.
85. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment?Chest. 1999;115(3): 869-873.
86. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
87. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of lung function testing: The authors' replies to readers' comments. Eur Respir J. 2010;36(6):1496-1498.
88. Enright P, Brusasco V. Counterpoint: should we abandon FEV/FVC <0.70 to detect airway obstruction? Yes. Chest 2010 138 5 1040-1042
89. McCool FD, Tzelepis GE. Dysfunction of the diaphragm. N Engl J Med. 2012;366(10):932-942.